Box score
Alveus Therapeutics, Inc.
Reported $56.9M sold in a new Form D filed January 14, 2026 (Philadelphia, Pennsylvania).
- Biggest raise
- $56.9M filed Jan 14, 2026
- League
- Bio & Health Pharmaceuticals
- Based in
- Philadelphia, Pennsylvania
- Season rank
- #38 of 1,121 in the Bio & Health League; #417 of 10,745 overall (2026)
- Incorporated
- 2023
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-01-14 | New notice | $56.9M | $111M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2075856.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Verismo Therapeutics, Inc. | Bio & Health | $28M |
| 2 | Cagent Vascular, Inc. | Bio & Health | $24.5M |
| 3 | Tolerance Bio Inc. rookie | Bio & Health | $15.1M |
| 4 | Peca Labs, Inc. | Bio & Health | $12.8M |
| 5 | Lungpacer Medical, Inc. | Bio & Health | $12M |
| 6 | KoKo Medical, Inc. | Bio & Health | $8M |